Mak­e­na's ac­cel­er­at­ed ap­proval with­draw­al hear­ing set for Oc­to­ber as Co­vis wants to do more re­search

The long-await­ed FDA hear­ing to re­view Co­vis Phar­ma’s ac­cel­er­at­ed ap­proval for its con­tro­ver­sial preterm birth in­jec­tion, which failed its con­fir­ma­to­ry tri­al, will take place from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.